CLC Number:
| [1] |
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic Syndrome[J]. Lancet, 2014,383(9927):1503-1516.
doi: 10.1016/S0140-6736(13)61048-X pmid: 24290661 |
| [2] |
黄文秋, 王旖旎, 王晶石, 等. 192例成人噬血细胞淋巴组织细胞增生症患者的临床分析[J]. 中华血液学杂志, 2014,35(9):796-801.
doi: 10.3760/cma.j.issn.0253-2727.2014.09.003 |
| [3] |
Atteritano M, David A, Bagnato G, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review[J]. Eur Rev Med Pharmacol Sci, 2012,16(10):1414-1424.
pmid: 23104659 |
| [4] |
Ahn SS, Yoo BW, Jung SM, et al. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classificationcriteria for macrophage activation syndrome[J]. Semin Arthritis Rheum, 2017,47(2):216-221.
doi: 10.1016/j.semarthrit.2017.02.002 pmid: 28268026 |
| [5] |
Ravelli A, Minoia F, Davì S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis: A European League Against Rheumatism / American College of Rheumatology / Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Ann Rheum Dis, 2016,75(3):481-489.
pmid: 26865703 |
| [6] |
Ahn SS, Yoo BW, Jung SM, et al. Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease[J]. J Rheumatol, 2017,44(7):996-1003.
doi: 10.3899/jrheum.161286 pmid: 28412707 |
| [7] |
Liu AC, Yang Y, Li MT, et al. Macrophage activation syndrome in systemic lupus erythematosus: A multicenter, case-controlstudy in China[J]. Clin Rheumatol, 2018,37(1):93-100.
pmid: 28409239 |
| [8] |
Zhang M, Behrens EM, Atkinson TP, et al. Genetic defects in cytolysis in macrophage activation syndrome[J]. Curr Rheumatol Rep, 2014,16(9):439.
doi: 10.1007/s11926-014-0439-2 pmid: 25086802 |
| [9] |
Wang Y, Wang Z, Zhang J, et al. Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood[J]. PLoS One, 2014,9(9):e107386.
doi: 10.1371/journal.pone.0107386 pmid: 25233452 |
| [10] |
Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007,48(2):124-131.
doi: 10.1002/pbc.21039 pmid: 16937360 |
| [11] |
Davì S, Minoia F, Pistorio A, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2014,66(10):2871-2880.
doi: 10.1002/art.38769 pmid: 25044674 |
| [12] |
Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis[J]. J Pediatr, 2005,146(5):598-604.
doi: 10.1016/j.jpeds.2004.12.016 pmid: 15870661 |
| [13] |
La Rosee P, Horne A, Hines M, et al. Recommendations of the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019,133(23):2465-2477.
doi: 10.1182/blood.2018894618 pmid: 30992265 |
| [14] |
Tada Y, Inokuchi S, Maruyama A, et al. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?[J]. Rheumatol Int, 2019,39(1):97-104.
doi: 10.1007/s00296-018-4114-1 pmid: 30051293 |
| [15] |
Minoia F, Bovis F, Davì S, et al. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis[J]. Ann Rheum Dis, 2019,78(10):1357-1362.
doi: 10.1136/annrheumdis-2019-215211 pmid: 31296501 |
| [16] | Wang R, Li T, Ye S, et al. Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease [J/OL]. Ann Rheum Dis, (2019-10-14) [2020-06-25]. doi: 10.1136/annrheumdis-2019-216286. |
| [17] | 姚海红, 王旖旎, 张霞, 等. 67例成人巨噬细胞活化综合征的临床特征及治疗转归[J]. 北京大学学报(医学版), 2019,51(6):996-1002. |
| [18] |
Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy[J]. Nat Rev Rheumatol, 2016,12(5):259-268.
doi: 10.1038/nrrheum.2015.179 pmid: 27009539 |
| [19] |
Weiss ES, Girard-Guyonvarc’h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome[J]. Blood, 2018,131(13):1442-1455.
doi: 10.1182/blood-2017-12-820852 pmid: 29326099 |
| [1] | Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312. |
| [2] | Jiyan CHU, Ping LI, Jing TIAN, Diyu FU, Lin GUO, Rui SUN, Yadi LI. Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 175-183. |
| [3] | Yuan LIU, Guixiu SHI. Change from Sjögren syndrome to Sjögren disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1015-1017. |
| [4] | Yirui LIAN, Jingxuan LIU, Liang ZHAO, Jing ZHAO, Sitian ZANG, Yuhui LI. Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1018-1023. |
| [5] | Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031. |
| [6] | Wenhao LIN, Yang XIE, Fangqing WANG, Shuying WANG, Xiangjun LIU, Fanlei HU, Yuan JIA. Single-cell RNA sequencing of B cells reveals molecular typing in Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1032-1041. |
| [7] | Zhao XIANG, Li YANG, Jing YANG. Untargeted metabolomics reveals differential serum metabolites and metabolic pathways in patients with primary Sjögren syndrome and thrombocytopenia [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1042-1050. |
| [8] | Yayun ZHAO, Mengfan NI, Xue LI, Bei WANG, Gong CHENG, Jing HE, Yuebo JIN. Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1051-1060. |
| [9] | Jiajing PENG, Li CUI. Clinical features and prognosis of sarcoidosis with ocular lesions as the initial manifestation [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1061-1066. |
| [10] | Yajing GAO, Zhengfang LI, Mengsi MA, Lijun WU. Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1067-1073. |
| [11] | Xiaolin WANG, Shaoyi GUO, Dazhao CHEN, Xijie WEN, Yong HUA, Liang ZHANG, Qin ZHANG. A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1081-1088. |
| [12] | Xinfeng WU, Siliang MAN, Dazhao CHEN, Yong HUA, Xijie WEN, Yingyue DING, Liang ZHANG, Xiujuan HOU. A long-term review for radiographic parameters of hips in axial spondyloarthritis patients with end-stage hip involvement: A 24-year trend analysis from a single high-volume tertiary center [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1089-1095. |
| [13] | Jingwen LAN, Zhe CHEN, Yongjing CHENG, Like ZHAO. Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1101-1106. |
| [14] | Yanyan LI, Xiangjun LIU, Gongming LI, Chun LI, Yuan JIA. Clinic behavior and therapeutic status of patients with antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1107-1112. |
| [15] | Chun WEI, Yue YANG, Xinju ZHAO, Xu LIU, Yuan JIA. Systemic lupus erythematosus complicated by autoimmune nodopathy: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1174-1179. |
|
||